Natera’s Stronghold in Cancer Recurrence Tests Prompts Wood’s Ark to Expand Stake (opens in new tab)

Natera’s flagship product, Signatera is a personalized MRD blood test that detects cancer recurrence by identifying the unique DNA mutations.